SERPINA6
MOLECULAR TARGETserpin family A member 6
SERPINA6 (serpin family A member 6) is targeted by 23 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting SERPINA6
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Corticosterone | 1.10 | 2 |
| 2 | Hydrocortisone | 0.69 | 1 |
| 3 | Dehydroepiandrosterone | 0.69 | 1 |
| 4 | Prednisolone | 0.69 | 1 |
| 5 | Progesterone | 0.69 | 1 |
| 6 | Testosterone | 0.69 | 1 |
| 7 | 17-alpha-Hydroxyprogesterone | 0.69 | 1 |
| 8 | Aldosterone | 0.69 | 1 |
| 9 | Algestone | 0.69 | 1 |
| 10 | Androstenediol | 0.69 | 1 |
| 11 | Androstenedione | 0.69 | 1 |
| 12 | Androsterone | 0.69 | 1 |
| 13 | Cortisone | 0.69 | 1 |
| 14 | Dehydroepiandrosterone | 0.69 | 1 |
| 15 | Desoxycorticosterone | 0.69 | 1 |
| 16 | Dihydrotestosterone | 0.69 | 1 |
| 17 | Estriol | 0.69 | 1 |
| 18 | Estrone | 0.69 | 1 |
| 19 | Etiocholanolone | 0.69 | 1 |
| 20 | Hydrocortisone | 0.69 | 1 |
| 21 | Cervugid [Supplementary Concept] | 0.69 | 1 |
| 22 | Nandrolone C18 steroid with androgenic and anabolic properties. It is generally prepared from alkyl ethers of ESTRADIOL to resemble TESTOSTERONE but less | 0.69 | 1 |
| 23 | Pregnenolone | 0.69 | 1 |
About SERPINA6 as a Drug Target
SERPINA6 (serpin family A member 6) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 23 compounds with documented SERPINA6 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
SERPINA6 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.